NMR-METABOLITE-SIGNATURE FOR IDENTIFYING CANCER PATIENTS RESISTANT TO CDK4/6 INHIBITORS, ENDOCRINE THERAPY AND ANTI-HER2 THERAPY

摘要

A method of determining patient responsiveness to a drug by the use of spectroscopy to obtain patient metabolite data and relating that data to data obtained from a statistically significant group of patients taking the same drug in order to obtain a result indicating responsiveness of a particular patient to treatment with a particular drug.